Skip to main content
HR 2022 115th Congress House Health Administrative law and regulatory procedures Business records Department of Health and Human Services Fraud offenses and financial crimes Hazardous wastes and toxic substances Health information and medical records Infectious and parasitic diseases Licensing and registrations Medical education Medical research Organ and tissue donation and transplantation Product safety and quality

LATTS Act of 2017

Introduced: May 1, 2018 Introduced by: Gosar, Paul A. Republican · Arizona See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 7, 2017
Referred to the Subcommittee on Health.
Apr 6, 2017
Referred to the House Committee on Energy and Commerce.
Apr 6, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Label and Transport Tissues Safely Act of 2017 or the LATTS Act of 2017

This bill prohibits the sale of human tissue for research or education unless the seller has a non-transplant tissue bank license, each package of tissue is labeled with specified information, and each package is wrapped in the prescribed manner.

The Department of Health and Human Services (HHS) shall establish a process for the approval, suspension, and revocation of non-transplant tissue bank licenses.

False labeling of packages of human tissue is prohibited.

HHS or any accrediting body authorized by HHS is allowed to enter and inspect any facility that is subject to a non-transplant tissue bank license.

HHS shall recall any human tissue specimen that is an imminent or substantial hazard to public health.

The bill makes it unlawful to knowingly sell or otherwise transfer any human tissue specimen if the transfer affects interstate commerce.

What's happening now April 7, 2017

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 3
All 3 Republican 2
R
Norman, Ralph
South Carolina · May 16, 2018
Garrett, Thomas
· May 1, 2018
 R
Rutherford, John H.
Florida · May 17, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2022: LATTS Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-2022/
MLA
"H.R. 2022: LATTS Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-2022/.
Bluebook (legal)
H.R. 2022, 115th Cong. (2026), https://openamerica.io/bill/115-HR-2022/.
Markdown link
[H.R. 2022: LATTS Act of 2017](https://openamerica.io/bill/115-HR-2022/)
Report a problem